M. H. Schlageter

486 total citations
15 papers, 197 citations indexed

About

M. H. Schlageter is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, M. H. Schlageter has authored 15 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in M. H. Schlageter's work include Acute Myeloid Leukemia Research (5 papers), Retinoids in leukemia and cellular processes (4 papers) and Erythropoietin and Anemia Treatment (2 papers). M. H. Schlageter is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Retinoids in leukemia and cellular processes (4 papers) and Erythropoietin and Anemia Treatment (2 papers). M. H. Schlageter collaborates with scholars based in France. M. H. Schlageter's co-authors include Y Najean, Pierre Fenaux, Marie‐Elisabeth Toubert, Christine Chomienne, André Baruchel, Fabien Guidez, Eric Wattel, I Krawice, Sylvie Castaigné and Nathalie Cambier and has published in prestigious journals such as Blood, Clinical Chemistry and European Urology.

In The Last Decade

M. H. Schlageter

14 papers receiving 185 citations

Peers

M. H. Schlageter
John Townsend United Kingdom
M. H. Schlageter
Citations per year, relative to M. H. Schlageter M. H. Schlageter (= 1×) peers John Townsend

Countries citing papers authored by M. H. Schlageter

Since Specialization
Citations

This map shows the geographic impact of M. H. Schlageter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. H. Schlageter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. H. Schlageter more than expected).

Fields of papers citing papers by M. H. Schlageter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. H. Schlageter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. H. Schlageter. The network helps show where M. H. Schlageter may publish in the future.

Co-authorship network of co-authors of M. H. Schlageter

This figure shows the co-authorship network connecting the top 25 collaborators of M. H. Schlageter. A scholar is included among the top collaborators of M. H. Schlageter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. H. Schlageter. M. H. Schlageter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bohelay, G., Jason Shourick, A. Guyot, et al.. (2020). Paraneoplastic neutrophilic leukaemoid reaction in a patient with melanoma: association between tumour volume and leucocytosis. British Journal of Dermatology. 183(3). 579–580. 5 indexed citations
2.
Chaı̈bi, Pascal, Isabelle Gouin, Virginie Siguret, et al.. (2006). 7 High response rate to Epoetin Beta in elderly patients with myelodysplasia (MDS): results of a prospective study. Critical Reviews in Oncology/Hematology. 60. S26–S26. 1 indexed citations
3.
Cassinat, Bruno, et al.. (2002). Dosage du 27–29 sur AIA 600 II® Tosoh-Bioscience : Évaluation analytique et comparaison avec le dosage de CA 15-3 Kryptor® (Brahms). Immuno-analyse & Biologie Spécialisée. 17(6). 401–406. 1 indexed citations
4.
Cambier, Nathalie, M. H. Schlageter, Thierry Leblanc, et al.. (2001). All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia.. PubMed. 2(2). 97–102. 5 indexed citations
5.
Chevret, Sylvie, et al.. (2000). From guidelines to hospital practice: reducing inappropriate ordering of thyroid hormone and antibody tests. European Journal of Endocrinology. 142(6). 605–610. 26 indexed citations
6.
Cassinat, Bruno, Patricia Díaz Guardiola, Sylvie Chevret, et al.. (1999). Assessment of serum AFP levels as a new tool in screening and diagnosis in Fanconi patients. 1. 41215. 1 indexed citations
7.
Cambier, Nathalie, André Baruchel, M. H. Schlageter, et al.. (1997). Chronic myelomonocytic leukemia: from biology to therapy. PubMed. 39(2). 41–48. 41 indexed citations
8.
Toubert, Marie‐Elisabeth, Jean-Paul Guillet, Marielle Chiron, et al.. (1996). Percentage of free serum prostate-specific antigen: A new tool in the early diagnosis of prostatic cancer. European Journal of Cancer. 32(12). 2088–2093. 10 indexed citations
9.
Méria, P., Marie‐Elisabeth Toubert, Olivier Cussenot, et al.. (1995). Tumour-Associated TrypsinInhibitor and Renal CellCarcinoma. European Urology. 27(3). 223–226. 18 indexed citations
10.
Dubois, C, M. H. Schlageter, Fabien Guidez, et al.. (1994). Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood. 83(11). 3264–3270. 57 indexed citations
11.
Dubois, C, M. H. Schlageter, Fabien Guidez, et al.. (1994). Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood. 83(11). 3264–3270. 4 indexed citations
12.
Schlageter, M. H., Marie‐Elisabeth Toubert, María J. Guil, Marc Espié, & Y Najean. (1993). CA.549 et cancer du sein. Immuno-analyse & Biologie Spécialisée. 8(2). 105–112. 1 indexed citations
13.
Dombret, Hervé, et al.. (1991). Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia.. PubMed. 33(6). 445–8. 1 indexed citations
14.
Schlageter, M. H., et al.. (1990). Radioimmunoassay of erythropoietin: analytical performance and clinical use in hematology. Clinical Chemistry. 36(10). 1731–1735. 24 indexed citations
15.
Toubert, Marie‐Elisabeth, et al.. (1990). [Screening for cancer of the prostate using prostate-specific antigen].. PubMed. 19(24). 1139–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026